AG Raoul today announced an $8.25 million settlement with Mylan Inc. (Mylan), the company that sells the EpiPen, resolving concerns about the company’s anticompetitive conduct related to EpiPen products. Mylan’s alleged anticompetitive scheme resulted in the state of Illinois paying excess amounts for EpiPens purchased through its Medicaid and employee health benefits programs. Most of the money recovered will be split by the Illinois Department of Healthcare and Family Services for its Medicaid purchases and the Illinois Department of Central Management Services for its purchases for employee health benefits programs.   

“I am proud of my office’s work to hold pharmaceutical companies accountable for engaging in business practices that result in Illinoisians paying more money for the prescription medication they need. I am committed to stopping unlawful and unfair tactics that fuel health care inequity in Illinois and around the country.” - AG Raoul